Echo IQ’s EchoSolv AS gains FDA approval—AI-powered solution to tackle underdiagnosed Aortic Stenosis
Sydney-based AI medical technology company, Echo IQ Limited, has achieved a significant breakthrough with the US Food and Drug Administration (FDA) clearance for its EchoSolv ... Read More
Audeara secures $570,000 Clinico order for co-developed hearing earbuds
Audeara Limited, a prominent hearing health innovator, announced a significant purchase order from Clinico Inc., Taiwan's leading hearing aid retailer, valued at $570,000. The order ... Read More
Neuren Pharmaceuticals advances NNZ-2591 for Phelan-McDermid syndrome to Phase 3 clinical trial
Neuren Pharmaceuticals has secured approval from the United States Food and Drug Administration (FDA) to progress into the first-ever pivotal Phase 3 clinical trial of ... Read More
Chimeric Therapeutics announces breakthrough AML response with CHM CORE-NK in Phase 1B trial
Chimeric Therapeutics has reported a significant milestone in its ongoing clinical trials, wherein a patient diagnosed with Acute Myelogenous Leukemia (AML) has exhibited a complete ... Read More
Immuron Limited reveals key findings from NMRC study, eyes future collaboration with U.S. DoD
Immuron Limited has announced the results of a Campylobacter human infection model study conducted by the U.S. Naval Medical Research Command (NMRC). The Melbourne-based biopharmaceutical ... Read More
Realty ONE Group partners with RMA Global to empower 20,000 agents
RMA Global Limited (ASX: RMY) has unveiled an exciting new partnership with Realty ONE Group, marking a significant milestone for both companies. This strategic agreement ... Read More
Noxopharm bags new funding to fuel game-changing cancer treatments
Noxopharm Limited, an Australian biotech powerhouse, has successfully raised A$2.1 million in funding through the issuance of convertible notes to sophisticated investors. This funding will ... Read More
Step One founder Greg Taylor sells stake amid investor surge
Step One Clothing Limited, the leading online direct-to-consumer innerwear brand, recently announced a significant development involving its founder and CEO, Greg Taylor. Taylor has agreed ... Read More
Pharma breakthrough! BioIntelect to revolutionise trials using Opyl’s cutting-edge tech
In a landmark collaboration, Opyl Limited announced a new six-month agreement with BioIntelect, a renowned Clinical Research Organisation (CRO) and strategic consulting firm in the ... Read More
Huge copper and gold finds at Bluebird: Tennant Minerals stock set for a rebound?
Tennant Minerals Limited (ASX: TMS) has announced a series of significant high-grade copper and gold intersections from its Bluebird discovery within the Barkly Project in ... Read More